Home / Companies / Clario (BioClinica, Inc.)

Clario (BioClinica, Inc.)

FDA Regulatory Profile

Clario (BioClinica, Inc.) has 0 FDA recalls, 13 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Jul 30, 2026 · NAI

Reviewing Clario (BioClinica, Inc.) as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Clario (BioClinica, Inc.) yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections13Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Recent FDA Inspections

DateSiteProductClassificationFEI
Jul 30, 2026Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Jun 25, 2026Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Apr 22, 2026Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Feb 23, 2026Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Aug 26, 2025Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Apr 22, 2025Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Jan 16, 2025Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Oct 11, 2024Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Jun 28, 2024Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Apr 12, 2024Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Mar 22, 2024Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Mar 21, 2024Philadelphia, PADrugsNo Action Indicated (NAI)1000103389
Feb 5, 2010Philadelphia, PADevicesNo Action Indicated (NAI)1000103389

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 1000103389Philadelphia, PA13Jul 30, 2026

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.